Literature DB >> 31677824

Understanding the Value of Tumor Markers in Pediatric Ovarian Neoplasms.

Amy E Lawrence1, Mary E Fallat2, Geri Hewitt3, Paige Hertweck4, Amanda Onwuka5, Amin Afrazi6, Christina Bence7, Robert C Burns8, Kristine S Corkum9, Patrick A Dillon10, Peter F Ehrlich11, Jason D Fraser12, Dani O Gonzalez1, Julia E Grabowski9, Rashmi Kabre9, Dave R Lal7, Matthew P Landman8, Charles M Leys6, Grace Z Mak13, R Elliott Overman11, Brooks L Rademacher6, Manish T Raiji13, Thomas T Sato7, Madeline Scannell10, Joseph A Sujka1, Tiffany Wright2, Peter C Minneci1, Katherine J Deans1, Jennifer H Aldrink14.   

Abstract

PURPOSE: The purpose of this study was to determine the diagnostic accuracy of tumor markers for malignancy in girls with ovarian neoplasms.
METHODS: A retrospective review of girls 2-21 years who presented for surgical management of an ovarian neoplasm across 10 children's hospitals between 2010 and 2016 was performed. Patients who had at least one concerning feature on imaging and had tumor marker testing were included in the study. Sensitivity, specificity, and negative and positive predictive values (PPV) of tumor markers were calculated.
RESULTS: Our cohort included 401 patients; 22.4% had a malignancy. Testing for tumor markers was inconsistent. AFP had high specificity (98%) and low sensitivity (42%) with a PPV of 86%. The sensitivity, specificity, and PPV of beta-hCG was 44%, 76%, and 32%, respectively. LDH had high sensitivity (95%) and Inhibin A and Inhibin B had high specificity (97% and 92%, respectively).
CONCLUSIONS: Tumor marker testing is helpful in preoperative risk stratification of ovarian neoplasms for malignancy. Given the variety of potential tumor types, no single marker provides enough reliability, and therefore a panel of tumor marker testing is recommended if there is concern for malignancy. Prospective studies may help further elucidate the predictive value of tumor markers in a pediatric ovarian neoplasm population. TYPE OF STUDY: Retrospective Cohort Review. LEVEL OF EVIDENCE: Level III.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Oophorectomy; Ovarian neoplasms; Ovary-sparing surgery; Preoperative risk; Tumor markers

Mesh:

Substances:

Year:  2019        PMID: 31677824      PMCID: PMC7181461          DOI: 10.1016/j.jpedsurg.2019.09.062

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  12 in total

1.  Pediatric ovarian neoplastic tumors: incidence, age at presentation, tumor markers and outcome.

Authors:  Seppo Taskinen; Riitta Fagerholm; Jouko Lohi; Mervi Taskinen
Journal:  Acta Obstet Gynecol Scand       Date:  2015-02-27       Impact factor: 3.636

2.  Ovarian-sparing surgery for ovarian teratoma in children.

Authors:  M Chabaud-Williamson; I Netchine; S Fasola; M Larroquet; M Lenoir; C Patte; J L Bénifla; A Coulomb-L'herminé; C Grapin; G Audry; F Auber
Journal:  Pediatr Blood Cancer       Date:  2011-03-02       Impact factor: 3.167

Review 3.  Malignant lesions of the ovary in childhood.

Authors:  Daniel von Allmen
Journal:  Semin Pediatr Surg       Date:  2005-05       Impact factor: 2.754

4.  Predictors of ovarian malignancy in children: overcoming clinical barriers of ovarian preservation.

Authors:  Jonathan C Papic; S Maria E Finnell; James E Slaven; Deborah F Billmire; Frederick J Rescorla; Charles M Leys
Journal:  J Pediatr Surg       Date:  2013-11-22       Impact factor: 2.545

5.  Preoperative risk stratification of children with ovarian tumors.

Authors:  Arin L Madenci; Bat-Sheva Levine; Marc R Laufer; Theonia K Boyd; Stephen D Voss; David Zurakowski; A Lindsay Frazier; Christopher B Weldon
Journal:  J Pediatr Surg       Date:  2016-05-31       Impact factor: 2.545

6.  Using quality improvement methodology to improve ovarian salvage for benign ovarian masses.

Authors:  Jennifer H Aldrink; Dani O Gonzalez; Stephen P Sales; Katherine J Deans; Gail E Besner; Geri D Hewitt
Journal:  J Pediatr Surg       Date:  2017-10-10       Impact factor: 2.545

7.  A Preoperative Scoring System for Adnexal Mass in Children and Adolescents to Preserve Their Future Fertility.

Authors:  Charlotte Depoers; Flore-Anne Martin; Krystel Nyangoh Timoh; Jeff Morcet; Maia Proisy; Sebastien Henno; Vincent Lavoue; Alexis Pierre Arnaud
Journal:  J Pediatr Adolesc Gynecol       Date:  2018-09-08       Impact factor: 1.814

8.  Ovarian masses in the child and adolescent: An American Pediatric Surgical Association Outcomes and Evidence-Based Practice Committee systematic review.

Authors:  Elizabeth J Renaud; Stig Sømme; Saleem Islam; Danielle B Cameron; Robert L Gates; Regan F Williams; Tim Jancelewicz; Tolulope A Oyetunji; Julia Grabowski; Karen A Diefenbach; Robert Baird; Meghan A Arnold; Dave R Lal; Julia Shelton; Yigit S Guner; Ankush Gosain; Akemi L Kawaguchi; Robert L Ricca; Adam B Goldin; Roshni Dasgupta
Journal:  J Pediatr Surg       Date:  2018-09-06       Impact factor: 2.545

9.  Ovarian-Sparing Surgery in Pediatric Benign Ovarian Tumors.

Authors:  Paulette I Abbas; Jennifer E Dietrich; Jessica A Francis; Mary L Brandt; Darrell L Cass; Monica E Lopez
Journal:  J Pediatr Adolesc Gynecol       Date:  2016-04-11       Impact factor: 1.814

10.  Can we preoperatively risk stratify ovarian masses for malignancy?

Authors:  Sarah C Oltmann; Nilda Garcia; Robert Barber; Rong Huang; Barry Hicks; Anne Fischer
Journal:  J Pediatr Surg       Date:  2010-01       Impact factor: 2.545

View more
  4 in total

1.  Long-term surgical outcomes in pediatric ovarian neoplasms: 20-year single-center experience.

Authors:  Bade Toker Kurtmen; Zafer Dokumcu; Emre Divarci; Orkan Ergun; Geylani Ozok; Ahmet Celik
Journal:  Pediatr Surg Int       Date:  2022-09-28       Impact factor: 2.003

2.  Ovarian lesions and tumors in infants and older children.

Authors:  Henning C Fiegel; Stefan Gfroerer; Till-Martin Theilen; Florian Friedmacher; Udo Rolle
Journal:  Innov Surg Sci       Date:  2021-08-11

3.  Imaging Appearance of Nongerminoma Pediatric Ovarian Germ Cell Tumors Does Not Discriminate Benign from Malignant Histology.

Authors:  Deborah Billmire; Bryan Dicken; Frederick Rescorla; Jonathan Ross; Jin Piao; Li Huang; Mark Krailo; Farzana Pashankar; Lindsay Frazier
Journal:  J Pediatr Adolesc Gynecol       Date:  2020-12-13       Impact factor: 2.046

4.  What Should Be the Topics of a Prospective Study on Ovarian Masses in Children?-Results of a Multicenter Retrospective Study and a Scoping Literature Review.

Authors:  Justyna Łuczak; Maciej Bagłaj; Piotr Dryjański; Alicja Kalcowska; Nastazja Banaszyk-Pucała; Maria Boczar; Krzysztof Dymek; Małgorzata Fryczek; Kaja Giżewska-Kacprzak; Wojciech Górecki; Andrzej Grabowski; Anna Gregor; Maria Jabłońska; Grzegorz Kowalewski; Magdalena Lewandowska; Maria Małowiecka; Anna Ogorzałek; Magdalena Pękalska; Aneta Piotrowska-Gall; Mateusz Porębski; Marek Siewiński; Dariusz Patkowski
Journal:  Curr Oncol       Date:  2022-02-28       Impact factor: 3.677

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.